Committee Membership

At the Annual Executive Conference, or as soon thereafter as convenient, the CHPA chair appoints the chair, vice chair, and members of CHPA committees. If you are interested in serving on one of CHPA's committees, please contact Phyllis Taylor.

Committees, Task Groups, & Working Groups

The following is a list of our committees. Please click on the name of a committee below to view its description, officers and members.

Acetaminophen PR/Education Working GroupAcetaminophen PR/Education Working Group

Develops national program to educate patients and consumers on how to safely use medicines containing acetaminophen.

Acetaminophen Task GroupAcetaminophen Task Group

Audit CommitteeAudit Committee

The Audit Committee has responsibility for overseeing the accounting procedures of the Association, and reviews the audit and management letter, making any appropriate recommendations.

Board of DirectorsBoard of Directors

The CHPA Board of Directors is the governing body of the Association, with the full power to do any and all things necessary in conducting the business of the Association. The Board sets overall policy and direction for the Association.

CBD Working GroupCBD Working Group

The CBD working group is a multi-disciplinary group that makes recommendations to the Board on CHPA policy for hemp-derived consumer products.

CHPA Educational Foundation Board of DirectorsCHPA Educational Foundation Board of Directors

CHPA Educational Foundation Board of Directors. Members of the CHPA Educational Foundation Board of Directors serve as governing bodies for the foundation's activities and financial health with fiduciary responsibility.

Consumer Medical Devices CommitteeConsumer Medical Devices Committee

Dietary Supplement CommitteeDietary Supplement Committee

The mission of the Dietary Supplements Committee (DSC) is to foster growth of the self-care business interests of member companies by building a predictable regulatory environment and positive public climate to help create favorable conditions for manufacturing and marketing safe, high quality dietary supplements.

DXM Task GroupDXM Task Group

Builds awareness of the dangers of teen cough medicine abuse through education, partnership programming, media, and community outreach.

Executive CommitteeExecutive Committee

The Executive Committee, a subcommittee of the Board of Directors, is composed of the Chair, the Chair-Elect, the immediate past Chair, and as many as ten additional persons appointed by the Chair from among the voting members of the Board. It considers problems arising between meetings of the Board of Directors, authorizes appropriate action, fixes staff compensation and its decisions and recommendations are reported to the next Board of Directors meeting.

Federal Government Affairs CommitteeFederal Government Affairs Committee

The Federal Government Affairs Committee (FGAC) is comprised of Washington representatives and government relations experts from CHPA member companies. The committee advises and assists CHPA staff in dealing with federal legislation and issues.

Finance CommitteeFinance Committee

The Finance Committee adopts ways and means to provide adequate revenues for the efficient and economical conduct of the affairs of the Association, including review and approval of the annual budget, subject to the approval of the Board of Directors.

Legal CommitteeLegal Committee

The Legal Committee reviews matters involving legal issues across federal or state government agencies, and takes required action or provides recommendations to the Board of Directors.

Membership CommitteeMembership Committee

Mission: The Membership Committee endeavors to increase the membership of the Association and ensure that it has a strong representative base by enlisting the interest of persons, firms, and corporations who are eligible for membership. Committee member responsibilities: • Participate in 1 to 2 conference calls per year to: 1. Assist CHPA staff in identifying companies in the OTC and nutritional supplement industries as potential targets for Brand & Private Label and Contract Manufacturer Membership. 2. Assist CHPA staff in identifying companies that provide materials or services to the OTC and nutritional supplement industries as potential targets for Associate Membership. • Where possible secure an introduction for CHPA staff to targets for any and all member classes. 1. Where possible, provide counsel to CHPA staff on potential strategies to approach targeted members.

Nominating CommitteeNominating Committee

The Nominating Committee nominates candidates for officers and members of the Board of Directors.

NSAIDS Task GroupNSAIDS Task Group

Task group objective is to support access to OTC medicines containing non-steroidal anti-inflammatory medicines.

Oral Discomfort Task GroupOral Discomfort Task Group

The objective of this task group is to generate clinical data in support of an indication of relief of tooth pain for benzocaine in children and adults. The Task Group is currently conducting a clinical trial to demonstrate the following objectives:

Pediatric Cough/Cold - PR Task GroupPediatric Cough/Cold - PR Task Group

Promotes the safe use of pediatric cough and cold products in children four years of age and older through education.

Pediatric Cough/Cold Pharmacokinetics ResearchPediatric Cough/Cold Pharmacokinetics Research

Comprised of CHPA member companies that particiated in the the pediatric cough/cold pharmacokinetics research program.

PQMC Compendial SubcommitteePQMC Compendial Subcommittee

CHPA's PQMC Compendial Subcommittee represents OTC interests on compendial issues by engaging in U.S. Pharmacopeial (USP) activities, conferences, and workshops. The group provides a delegate every five years to the USP Council of the Convention who helps develop and votes on resolutions that designate USP's next five year plan.

PQMC Stability SubcommitteePQMC Stability Subcommittee

CHPA's PQMC Stability Subcommittee evaluates current relevant issues that pertain to OTC drug product stability. This group provides a forum for development of industry-wide voluntary standards and procedures.

PQMC USP Monograph Modernization SubcommitteePQMC USP Monograph Modernization Subcommittee

Develops a science- and risk-based approach for the handling of impurities and degradation products in OTC monograph drug products.

Presidents' ForumPresidents' Forum

The Presidents’ Forum is made up of CEO’s from mid-small tier companies. The purpose of the Forum is to identify and provide information, insights, and opportunities for intra-member discussion on issues and concerns relevant to mid-small tier companies, to facilitate dialogue with top executives of significant retailers to recognize the specific needs of these companies and ensure that they are as integrally engaged as their larger OTC counterparts. Additionally, the Forum is an environment where members can learn from each other’s experiences, and enable them to forge relationships, and maintain a vehicle for expressing concerns and issues to be added to CHPA’s general agenda, that might not naturally emerge from CHPA’s normal course of business.

Product Quality & Manufacturing Committee (PQMC)Product Quality & Manufacturing Committee (PQMC)

The Product Quality Manufacturing Committee (PQMC) represents over-the-counter (OTC) interests on manufacturing and quality issues by participating in activities that will lead to clear and reasonable regulation/guidance, based on risk analysis and science. The committee works proactively with USP and regulatory agencies to develop an environment where consumer healthcare firms are able to provide safe and high quality products in a cost-effective manner. In addition, the PQMC continues to support cGMP-related training programs and provides a forum for technical information exchange as a service to members of the consumer healthcare industry.

Proposition 65 - Acetaminophen Task Group - GeneralProposition 65 - Acetaminophen Task Group - General

The purpose of this task group is to conduct and publish an up-to-date review of the literature regarding acetaminophen and cancer, to be available to the State of California (OEHHA) as they consider this chemical for listing as a carcinogen under Proposition 65.

PSE Task GroupPSE Task Group

Full PSE task group, made up from PSE Company Staff, PSE Federal, Pseudoephedrine Steering Committee, and PSE PR Task Group.

Public Affairs and Communications CommitteePublic Affairs and Communications Committee

The Public Affairs & Communications Committee considers communications, media, public relations, and public affairs matters affecting the consumer healthcare industry and advises the association on strategies to advance the visibility and interests of the industry.

Regulatory & Scientific Affairs CommitteeRegulatory & Scientific Affairs Committee

The Regulatory & Scientific Affairs Committee (RSAC) works with FDA and other scientific and medical stakeholders to support consumer access to safe and effective OTC medicines and dietary supplements and to manage issues confronting members.

Retail Liaison CommitteeRetail Liaison Committee

To relentlessly pursue industry growth for CHPA, its members and the retailer community through innovative, business-building forums focused on promoting mutual learning, understanding, and insights.

State & Local Government Affairs CommitteeState & Local Government Affairs Committee

The State & Local Government Affairs Committee (SGAC) is comprised of member company representatives who advise and assist the CHPA state & local government affairs staff on matters involving state and local legislation and regulations, provide a forum for discussion on emerging state issues relating to the regulation of OTCs and dietary supplements, and help determine CHPA's state & local government affairs priorities.

Supply Chain CommitteeSupply Chain Committee

The Supply Chain Committee (SCC) considers matters relating to supply chain and logistics issues as they uniquely relate to the consumer healthcare products industry and develops programming to inform and educate CHPA members about pending legislation, emerging technology, opportunities, and business practices in the supply chain/logistics arena.